Jacques Rachelle Suzanne 4
4 · Corbus Pharmaceuticals Holdings, Inc. · Filed May 19, 2022
Insider Transaction Report
Form 4
Jacques Rachelle Suzanne
Director
Transactions
- Award
Stock Option(right to buy)
2022-05-18+79,600→ 79,600 totalExercise: $0.33Exp: 2032-05-18→ Common Stock (79,600 underlying)
Footnotes (1)
- [F1]The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant.